phenylacetic acid has been researched along with Cystadenocarcinoma, Serous in 1 studies
phenylacetic acid : A monocarboxylic acid that is toluene in which one of the hydrogens of the methyl group has been replaced by a carboxy group.
Cystadenocarcinoma, Serous: A malignant cystic or semicystic neoplasm. It often occurs in the ovary and usually bilaterally. The external surface is usually covered with papillary excrescences. Microscopically, the papillary patterns are predominantly epithelial overgrowths with differentiated and undifferentiated papillary serous cystadenocarcinoma cells. Psammoma bodies may be present. The tumor generally adheres to surrounding structures and produces ascites. (From Hughes, Obstetric-Gynecologic Terminology, 1972, p185)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ferrandina, G | 1 |
| Melichar, B | 1 |
| Loercher, A | 1 |
| Verschraegen, CF | 1 |
| Kudelka, AP | 1 |
| Edwards, CL | 1 |
| Scambia, G | 1 |
| Kavanagh, JJ | 1 |
| Abbruzzese, JL | 1 |
| Freedman, RS | 1 |
1 other study available for phenylacetic acid and Cystadenocarcinoma, Serous
| Article | Year |
|---|---|
Growth inhibitory effects of sodium phenylacetate (NSC 3039) on ovarian carcinoma cells in vitro.
Topics: Antimetabolites, Antineoplastic; Apoptosis; Cisplatin; Cystadenocarcinoma, Serous; Dose-Response Rel | 1997 |